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Baker’s yeast Saccharomyces cerevisiae is one of the most impor-
tant and widely used cell factories for recombinant protein pro-
duction. Many strategies have been applied to engineer this yeast
for improving its protein production capacity, but productivity is
still relatively low, and with increasing market demand, it is im-
portant to identify new gene targets, especially targets that have
synergistic effects with previously identified targets. Despite im-
proved protein production, previous studies rarely focused on pro-
cesses associated with intracellular protein retention. Here we
identified genetic modifications involved in the secretory and traf-
ficking pathways, the histone deacetylase complex, and carbohy-
drate metabolic processes as targets for improving protein secretion
in yeast. Especially modifications on the endosome-to-Golgi traffick-
ing was found to effectively reduce protein retention besides
increasing protein secretion. Through combinatorial genetic ma-
nipulations of several of the newly identified gene targets, we
enhanced the protein production capacity of yeast by more than
fivefold, and the best engineered strains could produce 2.5 g/L of a
fungal α-amylase with less than 10% of the recombinant protein
retained within the cells, using fed-batch cultivation.
cell engineering | protein secretion | yeast cell factories | intracellular
protein retention | endosome-to-Golgi trafficking
Recombinant protein production by cell factories has been atthe center of the biotech industry since it was established
with the introduction of recombinant insulin and human growth
hormone in the 1980s. Today, the market size of biopharmaceutical
proteins and industrial enzymes reached hundreds of billions and
tens of billions of US dollars per year worldwide, respectively (1, 2).
The key for success in this industry is constant improvement of the
protein production capacity of the applied cell factories. Although
many organisms can be used as cell factories for protein production,
some expression systems, such as Escherichia coli, the yeast Sac-
charomyces cerevisiae, and Chinese hamster ovary cells, are pre-
ferred in consideration of quality, quantity, and cost of produced
proteins (3, 4).
S. cerevisiae is widely used for production of biopharmaceutical
proteins, but it is also used as a model organism for studying the
protein secretory pathway (5–7). Continuous efforts to improve
the yeast’s protein production capacity has not only resulted in
better cell factories for protein production, but also increased our
understanding of the entire protein secretory pathway (8, 9).
Given the model organism status of S. cerevisiae, knowledge and
experience generated based on S. cerevisiae are also valuable to
provide guidelines to engineer other cell factories for efficient
protein production. However, full understanding of the underlying
mechanisms of the molecular and genetic interactions underpin-
ning protein secretion are still lacking, Therefore, identification of
new gene targets, especially targets that have synergistic effects
with previously identified targets, is desirable to further engineer
this cell factory for efficient protein production (10, 11). Although
previous studies suggested various strategies for improving protein
production at different levels including transcription, translation,
posttranslational processes, etc. (12–17), they rarely focused on
processes associated with intracellular retention of the protein in
the secretory pathway.
In our earlier work (18), we isolated mutant yeast strains with
increased protein secretion from yeast UV mutagenesis libraries
through microfluidic droplet screening. Mutations in these mu-
tant strains were identified through whole genome sequencing
and classified according to the processes which they were in-
volved in. As increased protein secretion of these mutant strains
was caused by mutation in specific genes, these genes can po-
tentially be used as metabolic engineering targets for the design
of cell factories with improved protein secretory capacity. Single
deletion of some of these targets was shown to have a positive
effect on protein production (18), but not all targets identified
were evaluated, and possible synergistic effects of these muta-
tions were also not evaluated. Here we therefore used this study
to identify several targets for genetic modifications, and we
demonstrated that many of these targets have synergistic effects.
Thus, through engineering yeast at these targets we could reduce
protein retention and significantly increase protein secretion in
yeast resulting in the production of 2.5 g/L of a fungal α-amylase
in a fed-batch cultivation.
Significance
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engineering other cell factories for efficient protein secretion.
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Results and Discussion
Evaluation of Target Genes on Protein Secretion and Retention.
Based on a mutated gene list obtained from our previous study
(18), genes involved in the secretory and trafficking pathways
(such as ECM3, EMC1, ERV29, GOS1, VPS5, TDA3, COG5, and
SNC2), genes with similar functions appearing in different
strains (HDA2 and HDA3) and genes with nonsense mutation
from enriched GO terms (such as TAN1 from tRNA processing,
PGM2 from the carbohydrate metabolic process, and PXA1 from
lipid transport) (SI Appendix, Fig. S1) were selected for evalua-
tion of their association with protein secretion and retention
using single gene deletions. To enable an initial screening of
these different targets, we used the BY4742 strain background
for which there is a single gene-deletion library available, but
consistent with our earlier study we used amylase as a model
protein. Amylase production varied in the BY4742 strains with
single gene deletion with some having increased amylase secre-
tion and others having reduced amylase secretion compared with
the reference strain (SI Appendix, Fig. S2B). Besides changes in
the amylase yield, intracellular amylase proportion was also
found to be altered by gene deletion (SI Appendix, Fig. S2C).
These results indicated that identified mutant genes involved in
the secretory pathway and from enriched GO terms affected
protein production and could be used as potential engineering
targets for improving protein production.
Engineering of Endosome-to-Golgi Trafficking and the Histone
Deacetylase Complex Increases Protein Secretion. To explore these
genes for cell factory construction, the four genes (HDA2, VPS5,
GOS1, and TDA3) in which deletion led to the highest im-
provement in amylase production in the BY4742 strain back-
ground were chosen for further investigation in the CEN.PK
strain background, which is the strain background used in our
previous studies (8, 18). Single gene deletions of HDA2, VPS5,
and TDA3 also increased amylase secretion in the CEN.PK
strain background (Fig. 1A). To test whether there was additivity
in the enhancing effect on amylase secretion of the target genes,
combinatorial gene deletions were performed. AsGOS1 deletion
has a significant positive effect on amylase secretion in the
BY4742 strain background, it was also included as a gene target
in the combinatorial gene-deletion studies. Compared with the
control strain K01, the amounts of secreted amylase after 96 h in
tube fermentation increased fourfold and 4.5-fold in the triple
gene-deletion strain K10 (Δhda2, Δvps5, and Δtda3) and the
quadruple gene-deletion strain K11 (Δhda2, Δvps5, Δtda3 and
Δgos1), respectively (Fig. 1A). The total amount of amylase
production (secretion and intracellular retention) by strains with
combinatorial gene deletion was presented in SI Appendix, Fig.
S3. Furthermore, the final cell dry weight of the strains K10 and
K11 were found to be slightly lower than that of the control
strain K01 (Fig. 1C).
Hda2p is a subunit of the HDA1 histone deacetylase complex,
which is involved in the TUP1-specific repression and global
deacetylation in yeast (19, 20). The likely mechanism for the
beneficial effect of the hda2 deletion on protein production was
the release of TUP1 repression, which has been shown to in-
crease amylase production (8). Gos1p is involved in Golgi
transport, and the deletion of GOS1 reduces efficiency of ret-
rograde Golgi traffic (21), which might have a beneficial effect
on amylase secretion. Previously, balanced trafficking between
the endoplasmic reticulum (ER) and the Golgi was shown to
improve protein secretion (22), but clearly anterograde traf-
ficking in the Golgi also represents a potential pathway to be
engineered for achieving balanced trafficking within the Golgi.
The deletion of VPS5 significantly reduced intracellular amy-
lase retention, and only around 10% of totally produced amylase
was retained intracellularly in the engineered strains with the
vps5 deletion (Fig. 1B). According to the literature, Vps5p forms
a retromer subcomplex with Vps17p and interacts with another
subcomplex, which consists of three proteins (Vps26p, Vps29p,
and Vps35p), all involved in protein trafficking from the late
A
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Fig. 1. Combinatorial gene deletions improve amylase secretion in a CEN.
PK strain. (A) α-Amylase yield of engineered strains. (B) Intracellular α-amylase
retention of engineered strains. (C) Biomass of engineered strains. Strains
were cultivated in an SD-2×SCAA medium at 30 °C for 96 h for α-amylase
production. Data shown are mean values ±SDs of biological duplicates
of single clones. The statistical significance was determined by a two-
tailed homoscedastic (equal variance) t test and indicated with an asterisk
if P < 0.05.
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endosome to the late Golgi (23, 24) (Fig. 2A). Due to the in-
teraction with a protein with a known effect on amylase secre-
tion, the effects on amylase secretion by deletion of VPS17 was
also tested. A similar result to the effects of the vps5 deletion was
observed with both increased amylase yield and decreased in-
tracellular amylase retention found in the vps17 deletion strain
after 96 h cultivation (Fig. 2 B and C). The total amount of
amylase produced by the vps17 deletion strain was also similar to
the vps5 mutant strain (SI Appendix, Fig. S4). Increased amylase
production as a consequence of both vps5 and vps17 deletions
revealed the importance of trafficking between the Golgi appa-
ratus and the endosome in protein secretion. In a previous study,
Vps10p was shown to have a shortened lifetime in vps5 mutants
(25). We therefore also constructed a vps10 mutant strain and
measured extracellular and intracellular amylase. The result
showed that deletion of vps10 reduced amylase retention (SI
Appendix, Fig. S5), yet the protein secretion improvement was
less than what was observed for the vps5 mutant. This indicated
that a disrupted retromer complex can improve protein secretion
not only through vps10 degradation, but also through other
pathways. Another of our target genes, TDA3, is also involved in
transport from the late endosome to the Golgi apparatus. Tda3p
regulates endosomal protein trafficking of specific proteins (e.g.,
Kex2p and Yif1p) through negative regulation of Btn2p (SI
Appendix, Fig. S6A), and deletion of TDA3 has been shown to
result in stronger Kex2p association with the Golgi apparatus
(26). As the α factor leader sequence used for guiding amylase
secretion contains a Kex2 cutting site (27), the amylase matu-
ration in the Golgi requires Kex2p processing to remove the
profragment (SI Appendix, Fig. S6B). Increased amylase secre-
tion in the TDA3 deletion strain was likely the result of more
available Kex2p in the Golgi for amylase maturation. This was
confirmed by overexpression of BTN2, which also increased
amylase secretion (SI Appendix, Fig. S6 C and D), whereas
overexpression of TDA3 did not significantly reduce amylase
production (SI Appendix, Fig. S6 C and D).
Strengthening of Anterograde Trafficking Increases Protein Secretion.
Two genes of the gene deletions found from our initial screening
in the BY4742 strain background, namely, ERV29 and COG5,
reduced rather than increased amylase secretion (18). Erv29p is a
transmembrane receptor for the incorporation of certain soluble
cargo proteins into COPII-coated vesicles (28). The proregion of
an α-factor signal peptide can mediate the cargo protein into
COPII vesicles via Erv29p-dependent transport (29, 30). Cog5p is
a subunit of the conserved oligomeric Golgi complex, which me-
diates retrograde vesicles trafficking to the Golgi and within the
Golgi (31). This led us to speculate that overexpression rather
than deletion of ERV29 and COG5 might increase amylase se-
cretion, which we tested in the CEN.PK strain. As shown in the SI
Appendix, Fig. S7, single gene overexpression of COG5 and
ERV29 improved amylase secretion and/or decreased the in-
tracellular amylase retention. As amylase was led by the α-factor
signal peptide for secretion in this study, it is likely that the am-
ylase changed in the ERV29 overexpressed strain was related to
enhancement of the Erv29p-dependent transport. This was in
agreement with the decreased amylase production in the erv29
deletion strain, which lost the Erv29p-dependent transport (SI
Appendix, Fig. S2A). Overexpression of COG5 might strengthen
retrograde vesicles trafficking, which was beneficial for amylase
production. However, combinatorial overexpression of the two
genes (ERV29 + COG5) only decreased intracellular amylase re-
tention without a concomitant increase in amylase secretion. A
possible explanation for the lack of increase in amylase secretion in
the combined overexpressed strains is that the plasmid-based mul-
tiple gene overexpression imposed an extra burden on cells which
led to the competition for resources with the amylase production. A
similar phenomenon was observed in a previous study where single
gene overexpression had a better performance than multiple gene
overexpression for enhancing protein production (32).
Promotion of Protein Secretion by Multiple Genetic Manipulations.
To reduce the metabolic burden and increase cell stability for
recombinant protein production, strong promoter replacement
was applied for overexpression of the target genes instead of
plasmid-based overexpression. As the looping out of the amdS
marker gene from the quadruple gene-deletion strain K11 (de-
letions of HDA2, VPS5, TDA3, and GOS1) was not successful for
unknown reasons, promoter replacement was performed on the
A
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Fig. 2. The retromer complex affects amylase secretion. (A) Schematic of
the retromer complex. (B) Amylase yield of the vps17 deletion strain. Strain
names are in the bottom line. (C) Intracellular amylase retention of the
vps17 deletion strain. Strains were cultivated in a SD-2×SCAA medium at
30 °C for 96 h for α-amylase production. Data shown are mean values ±SDs
of biological duplicates of single clones. The statistical significance was de-
termined by a two-tailed homoscedastic (equal variance) t test and indicated
with an asterisk if P < 0.05.
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triple gene-deletion strain K30 (deletion of HDA2, VPS5, and
TDA3) instead. Compared with strain K30, amylase secretion
increased by 12% in the strain K13 where the native COG5
promoter was replaced with a strong PGK1p promoter (Fig. 3A).
However, replacement of the native ERV29 promoter with the
strong TEF1p promoter in strain K12 did not increase amylase
production in the triple gene-deletion strain K30.
In our previous study (18), we found that chromosome III was
duplicated in several mutant strains, including in the best protein
secretion mutant strain B184. The PDI1 gene, which plays an
important role in assisting the protein folding in the ER (33) and
was shown to increase protein secretion when overexpressed (16,
34), is located on chromosome III. As amylase production was
increased by PDI1 overexpression (SI Appendix, Fig. S8), eleva-
tion of PDI1 expression in the mutant strains was likely con-
tributing to increased amylase secretion. We were interested in
whether our gene modifications had additive effects on the
overexpression of PDI1 and if the amylase production capacity of
the engineered strains could be further increased. Therefore,
both promoter replacement and gene integration were tested for
the PDI1 gene. As deletion of GOS1 had positive effects on the
protein secretion (Fig. 1A), the position chosen for the in-
tegration of one copy of the PDI1 gene was the GOS1 locus. The
integration of PDI1 was thus achieved through replacement of
GOS1. As shown in Fig. 3A, the overexpression of PDI1 had an
additive effect on the enhancement of amylase secretion with the
other gene modifications. An integration of TEF1p-PDI1 on the
GOS1 locus (strain K17) showed a 24% increase in amylase
production, compared with strain K13. The levels of intracellular
amylase retention remained low in all of the engineered strains
with different combinatorial modifications (Fig. 3B). The bio-
mass of the best engineered strain K17 was, however, lower than
the reference strain (Fig. 3C). The total amount of amylase
produced by strains with multiple genetic manipulations was
shown in SI Appendix, Fig. S9.
Identified Genes Show General Positive Effects on Protein Secretion.
To test whether the selected genetic modifications have a gen-
eral positive effect on protein secretion in addition to the posi-
tive effect on amylase secretion, another heterologous protein,
glucan 1,4-α-glucosidase was expressed in the engineered strain
CEN.PK 530–1CK303, which was generated by removing the
amylase expression plasmid from strain K17 and contained opti-
mized combinatorial gene modifications for amylase production
(SI Appendix, Fig. S10). A higher glucan 1,4-α-glucosidase yield
was achieved in the engineered strain compared with the refer-
ence strain. This result supported the hypothesis that the identi-
fied gene targets had a general positive effect on protein production
by yeast.
Currently, many strains used for protein production in industry
are already engineered or mutated. Therefore, it is interesting to
evaluate newly identified gene targets not only using the refer-
ence strain, but also in engineered strains. We therefore evalu-
ated if two of the identified gene targets, i.e., VPS5 and TDA3
involved in the endosome-to-Golgi trafficking pathway, could
further improve protein secretion by strain B184, which we
earlier generated by UV mutation and selection (18). As shown
in SI Appendix, Fig. S11, the strain B184 with a vps5 mutant
or/and a tda3 mutant had a higher amylase yield and less amylase
intracellular retention. These results supported our findings that
identified gene targets have a wide application on cell engineering
for protein production.
Protein Production of the Best Engineered Strain K17 on the Bioreactor
Scale. To explore the industrial applicability of the engineered
strain with selected gene modifications, the protein production
capacity of the best engineered strain K17 was verified using batch
fermentations in a bioreactor with the strain K01 used as a
A
B
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D
Fig. 3. Combinatorial engineering of strains with multiple genetic manip-
ulations. (A) α-Amylase yield of engineered strains with gene deletions,
promoter replacements, and gene integrations. (B) Intracellular α-amylase
retention of engineered strains. (C) Biomass of engineered strains. (D)
Schematic showing engineered target genes in the best strain K17. Strains
were cultivated in a SD-2×SCAA medium at 30 °C for 96 h for α-amylase
production. Data shown are mean values ±SDs of biological duplicates of
single clones. The statistical significance was determined by a two-tailed
homoscedastic (equal variance) t test and indicated with an asterisk if
P < 0.05.
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reference. Strain K17 showed higher amylase yield throughout
the whole fermentation process compared with the reference
strain (Fig. 4 A and B). Furthermore, the intracellular amylase
retention of strain K17 remained at a significantly lower level
compared with the reference (Fig. 4C). Strain K17 had a re-
duced final biomass yield (Fig. 4D), which was in agreement
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with the previous finding that decreased biomass formation was
favorable for protein production (8). A lower maximum specific
growth rate and a lower glycerol production on glucose were
found for strain K17 (Fig. 4E). Strain K17 also had a lower
specific glucose uptake rate, a lower specific ethanol production
rate, and a lower specific glycerol production rate (SI Appendix,
Fig. S12). The lower specific glucose uptake rate of strain
K17 resulted in a lower growth rate and decreasing overflow
metabolism, which should lead in a higher biomass yield (35).
In contrast, a reduced final biomass yield in strain K17 was
observed, suggesting that resources were redirected from bio-
mass formation to amylase production.
As the industrial application of S. cerevisiae for protein pro-
duction is often performed using fed-batch processes (36), the
protein production capacity of the best strain K17 was also explored
in a fed-batch culture. Up to 98.5 g dry cell weight/L (g-DCW/L) of
cell density was achieved at the end of a 156 h cultivation period
with a total of 327 g/L glucose consumed (key process values shown
in SI Appendix, Fig. S13). The final α-amylase titer reached 2.5 g/L
(Fig. 5), which is a very high protein titer. Also, the intracellular
α-amylase retention remained at a low level (with the peak value of
12% and below 10% for the majority of time) during the whole
process. Medium feeding was controlled based on setting the
growth rate and dissolved oxygen level to avoid an overflow me-
tabolism, and virtually no ethanol accumulated during the feeding
phase. Surprisingly, glycerol accumulated gradually with the
medium feeding and reached a peak value at around 108 h after
which it was consumed. Strain K17 maintained a relatively
stable specific amylase productivity (0.4–0.5 mg/g DCW·h)
during the feeding phase but decreased during the last day (SI
Appendix, Fig. S14). The biomass concentration kept increasing
during the last day, and the cell density reached >90 g DCW/L.
Decreased protein productivity in the last day suggested that
the culture environment was unable to fully support cells re-
leasing their potential for heterologous protein production as
nutrient and oxygen demands for the cells basic metabolic
consumption increased at a higher cell density.
Conclusion
To summarize, our work identified several targets involved in the
secretory and trafficking pathways and histone deacetylase
complex for the improvement of protein secretion. Our study
demonstrates that deletions of VPS5 and VPS17 substantially
enhance heterologous protein secretion and reduces intracellular
heterologous protein retention. The involvement of both of these
genes in the transport between Golgi and endosome suggests
that this pathway is a promising avenue for further exploration in
the design of efficient cell factories for protein production. Our
results also indicate that, although gene overexpression may help
to ease bottlenecks in protein production, it may also compete
for resources with the production of the target protein. It was
therefore important to balance benefits in the enhancement of
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Fig. 5. Fed-batch cultivation of the best engineered strain K17. Cells were cultured in a SD-2×SCAA medium with condensed medium feeding. Detailed
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protein production with this competition for resources, which
can be achieved by controlling gene overexpression levels. Both
batch and fed-batch cultivation results of strain K17 confirmed
that the protein secretion was substantially improved in the yeast
strain with combinatorial modifications. Strain K17 exhibited
protein production capacity with titers at the gram-liter level
(2.5 g/L amylase) in fed-batch cultures, a big leap from the
milligram-liter level through strain engineering. The engineered
strain was able to adapt to the high density cultivation and
showed a potential for industrial application. Modifications of
the gene targets presented in this study had generalized en-
hancement effects on protein production and were compatible
with additional genetic modifications. As a consequence, they
can be used for engineering both wild type strains and existing
engineered strains to promote protein production. Here, by
measuring the distribution of intracellular and extracellular amy-
lase, we also showed the effects of gene modifications on protein
secretion from another angle. Protein intracellular retention can
be used as a useful parameter to evaluate gene targets and engi-
neer strains in future studies. It should be mentioned that, al-
though the intracellular amount of protein was determined by
the secretion capacity of the cell, other mechanisms including in-
tracellular degradation and/or increased protein synthesis might
also affect the protein retention and secretion. Moreover, as
S. cerevisiae is a model organism, targets and engineering pathways
identified here are most likely to provide general guidelines for
the design and construction of other cell factories for efficient
protein production.
Methods
Strains, Plasmids, and Primers Used in This Study. All strains and plasmids used
in this study are listed in SI Appendix, Table S1. All primers used in this study are
listed in SI Appendix, Table S2. Gene deletions, promoter replacements, and
gene replacements in the CEN.PK strain were performed through homologous
recombination by using amdS as a selection marker (37). Gene-deletion cas-
settes were amplified from the plasmid pUG-amdSYM for the amdS marker
flanking with homologous regions to the target genes. Gene replacement
cassettes or promoter replacement cassettes were constructed by fusion of the
integrated gene or promoter with the amdS marker, and the fusion fragment
(integrated gene plus amdS marker) was also flanked by homologous regions
of the target genes. Transformants were selected on the SM-Ac plates for
homologous recombination, and the counterselection for looping out the
amdS marker was performed on the SM-Fac plates by following the proce-
dures described previously (37). Genes for overexpression were amplified from
the yeast genome and then inserted into the plasmid pSP-GM1 (SI Appendix,
Fig. S4D). Cassettes or plasmids were introduced into the yeast by the standard
LiAc/SS DNA/PEG transformation method (38).
Media and Culture Conditions. The YPD medium contains 10 g/L yeast extract,
20 g/L peptone, and 20 g/L glucose. The YPE medium contains 10 g/L yeast
extract, 20 g/L peptone, 10 g/L ethanol, and 0.5 g/L glucose. The SD-ura
medium contains a 6.9 g/L yeast nitrogen base without amino acids, a
770 mg/L complete supplement mixture (CSM, without uracil), and 20 g/L
glucose. The amdS marker is selected by using the SM-Ac medium (37), which
contains 3 g/L KH2PO4, 0.5 g/L MgSO4·7H2O, 0.6 g/L acetamide, 6.6 g/L K2SO4,
1 mL/L of a trace element solution, and 1 mL/L of a vitamin solution. Counter-
selection of the amdS marker is carried out on SM-Fac medium, which contains
3 g/L KH2PO4, 0.5 g/L MgSO4·7H2O, 5 g/L (NH4)2SO4, 2.3 g/L fluoroacetamide,
1 mL/L of a trace element solution, and 1 mL/L of a vitamin solution. Twenty
gram-liter agar are added to the media when preparing agar plates. For protein
production in tubes or shake flasks, yeast strains were cultured at 30 °C and
200 rpm for 96 h in the SD-2×SCAA medium (39, 40) containing 20 g/L glucose,
6.9 g/L yeast nitrogen base without amino acids, 190 mg/L Arg, 400 mg/L Asp,
1260 mg/L Glu, 130 mg/L Gly, 140 mg/L His, 290 mg/L Ile, 400 mg/L Leu, 440 mg/L
Lys, 108 mg/L Met, 200 mg/L Phe, 220 mg/L Thr, 40 mg/L Trp, 52 mg/L Tyr,
380 mg/L Val, 1 g/L bovine serum albumin (BSA), 5.4 g/L Na2HPO4, and 8.56 g/L
NaH2PO4·H2O (pH = 6.0 by NaOH). For bioreactor cultivation, 5.4 g/L Na2HPO4
and 8.56 g/L NaH2PO4·H2O in the SD-2×SCAA medium were replaced by 2 g/L
KH2PO4 (pH = 6.0 by NaOH).
Protein Quantification. The α-amylase assay kit (Megazyme K-CERA) was used
for quantification of the α-amylase activity and a commercial α-amylase from
Aspergillus oryzae (Sigma-Aldrich) was used as the standard. The weight of
α-amylase can be converted with 69.6 U/mg as the α-amylase conversion
coefficient (27). Five hundred microliter cell cultures were centrifuged at
12,000 × g for 3 min with the liquid phase used for the measurement of
α-amylase in the supernatant and the cell pellet used for intracellular
α-amylase measurements. The cell pellet was washed with distilled water
and resuspended in 0.5 mL phosphate-buffered saline containing a 5 μL halt
protease inhibitor mixture (Thermo Fisher). The cell suspension was added to
a lysing matrix tube, and cell lysis was processed in a FastPrep-24 tissue and
cell homogenizer (MP Biomedicals) at the speed of 6.5 m/s for 2 min. Cell
debris was removed by centrifugation, and the supernatant fraction was
used for α-amylase quantification. The glucan 1,4-α-glucosidase was mea-
sured by using Amyloglucosidase Assay Reagent (Megazyme).
Batch Fermentation and Fed-Batch Fermentation. For the bioreactor batch
cultivation, 5.4 g/L Na2HPO4 and 8.56 g/L NaH2PO4·H2O in the SD-2×SCAA
medium were replaced by 2 g/L KH2PO4 (pH = 6.0 by NaOH). Strains were
first grown in seed cultures to the late exponential phase and then were
used to inoculate 500 mL SD-2×SCAA medium in 1 L bioreactor vessels
(DasGip) with an initial OD600 of 0.01. The bioreactor system was run at
30 °C, 600 rpm agitation, 30 L/h airflow, and pH = 6 (controlled by KOH).
Biological experiments were conducted in triplicate.
For the fed-batch cultivation, a 200 mL SD-2×SCAA medium was first in-
oculated with seed cultures of strain K17 (5.4 g/L Na2HPO4 and 8.56 g/L
NaH2PO4·H2O were replaced by 2 g/L KH2PO4) with an initial OD600 of 0.1.
The bioreactor system was run at 30 °C, 600 rpm [1 L bioreactor vessels
(DasGip)] as the initial agitation speed and increased to maximally 1200 rpm,
18 L/h as the initial airflow and increased to maximally 48 L/h, pH = 6
(maintained by using 4 M KOH and 2 M HCl), and the dissolved oxygen level
was maintained above 30% by controlling agitation speed, airflow, and
medium feeding. The low glucose 10× feed medium contained: 200 g/L
glucose, 69 g/L yeast nitrogen base without amino acids, 50 g/L casamino
acids (Formedium), 1 g/L BSA, and 20 g/L KH2PO4 (pH = 5 by KOH). For the
high glucose 10× feed medium, 200 g/L glucose in a low glucose 10× feed
medium was replaced with 600 g/L glucose. After the glucose and ethanol
were consumed in the batch culture (200 mL SD-2×SCAA medium), the ex-
ponential feed was started by using the low glucose 10× feed medium and
controlled at a specific growth rate of 0.08 h−1. When both the agitation
speed and the airflow reached the maximum values (1200 rpm and 48 L/h,
respectively) [1 L bioreactor vessels (DasGip)], medium feeding was triggered
by a dissolved oxygen level >25%. After feeding about 330 mL of the low
glucose 10× feed medium, a high glucose 10× feed medium was used. Fer-
mentation was stopped when 330 mL of the high glucose 10× feed medium
was fed in the bioreactor. In total, 660 mL of the feeding medium were
added to the bioreactor. Biological experiments on the fed-batch cultivation
were conducted in duplicate.
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